Renaissance Technologies
GCTK icon

Renaissance Technologies’s GlucoTrack GCTK Stock Holding History

Renaissance Technologies’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20
Closed -$8.96K – 3584
2024
Q4 		$8.96K Buy
+20
New +$25.4K ﹤0.01% 3522
2024
Q2 		– Sell
-2
Closed -$4K – 3668
2024
Q1 		$4K Buy
+2
New +$3.14K ﹤0.01% 3650

Other funds holding GCTK

AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies's GCTK Position: Q1 2025 in Review

Renaissance Technologies sold out of GlucoTrack (GCTK) in Q1 2025, closing a stake of 20 shares — an estimated $8.96K sold.

Renaissance Technologies first reported a position in GCTK in Q1 2024 and held it in 2 quarters. The position peaked at $8.96K in Q4 2024. 4 funds tracked by Wall St. Rank hold GCTK as of Q1 2025.

  • Renaissance Technologies reported no remaining GlucoTrack position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 20 GlucoTrack shares in Q1 2025, an estimated $8.96K.
  • Renaissance Technologies first reported a position in GlucoTrack in Q1 2024 and held it in 2 quarters.
  • Renaissance Technologies's GlucoTrack position peaked at $8.96K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.